Loading...
Targeting plasma membrane phosphatidylserine content to inhibit oncogenic KRAS function
The small GTPase KRAS, which is frequently mutated in human cancers, must be localized to the plasma membrane (PM) for biological activity. We recently showed that the KRAS C-terminal membrane anchor exhibits exquisite lipid-binding specificity for select species of phosphatidylserine (PtdSer). We,...
Na minha lista:
| Udgivet i: | Life Sci Alliance |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Life Science Alliance LLC
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6709719/ https://ncbi.nlm.nih.gov/pubmed/31451509 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.26508/lsa.201900431 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|